Donaueschingen (pta013/09.11.2021/08:50) - 09/11/2021: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 19% and EBIT by approx. 18% in the first nine months of 2021. As a result, the continually positive development of sales and earnings of the last years could be continued.
Sales improved from KEUR 115,474 to KEUR 137,223 (+18.8%) in the first nine months 2021. The international share of total business volume was 46.1% (9M 2020: 45.0%) and amounted to KEUR 63,268 compared to KEUR 52,011 (9M-2020).
The consolidated surplus rose very sharply by 23.1% to KEUR 11,110 (9M 2020: KEUR 9,024), and consolidated earnings before interest and taxes (EBIT) rose by 18.1% to KEUR 15,140 (9M 2020: KEUR 12,818): EBITA increased by 18.8% from KEUR 15,685 (9M-2020) to KEUR 18,639, and EBITDA increased by 11.5% to KEUR 27,605 (9M 2020: KEUR 24,762).
As of 30/09/2021, the company had cash resources at its disposal in the amount of KEUR 23,742 (31/12/2020: KEUR 28,177). Nexus AG had equity capital amounting to KEUR 132,137 as of 30/09/2021 (31/12/2020: KEUR 123,583). Consequently, the equity capital rate is 53.0% (31/12/2020: 55.4%).
The Managing Board(end)
|contact person:||Hannes Wehinger|
|phone:||+49 771 22960-260|
|stock exchanges:||regulated market in Frankfurt, Hamburg; free market in Dusseldorf, free market in Munich, free market in Stuttgart; open market in Berlin|